End-of-Life Care of Acute Myeloid Leukemia Compared with Aggressive lymphoma in Patients Who Are Eligible for Intensive Chemotherapy: An Observational Study in a Japanese Community Hospital

BACKGROUND: Patients with hematological malignancies (HMs) are reported to receive more aggressive care at the end of life (EOL) than patients with solid tumors. However, the reasons behind this occurrence are not fully understood. OBJECTIVES: To examine whether the care at EOL for HMs is mainly bec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kokaji, Masato, Imoto, Naoto, Watanabe, Miki, Suzuki, Yutaro, Fujiwara, Shinji, Ito, Rie, Sakai, Toshiyasu, Yamamoto, Satomi, Sugiura, Isamu, Kurahashi, Shingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029750/
https://www.ncbi.nlm.nih.gov/pubmed/36960234
http://dx.doi.org/10.1089/pmr.2022.0056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029750/
https://www.ncbi.nlm.nih.gov/pubmed/36960234
http://dx.doi.org/10.1089/pmr.2022.0056

Ejemplares similares